← BALCHEM CORP
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $553.2m |
$594.8m
+7.52%
|
$643.7m
+8.22%
|
$643.7m
+0.00%
|
$703.6m
+9.31%
|
$799.0m
+13.56%
|
$942.4m
+17.94%
|
$922.4m
-2.11%
|
$953.7m
+3.39%
|
$1.0b
+8.75%
|
$1.1b
+4.70%
|
|
| Cost of Goods and Services Sold | $372.3m |
$405.8m
+8.98%
|
$439.4m
+8.29%
|
$432.3m
-1.61%
|
$479.7m
+10.97%
|
$555.8m
+15.86%
|
$661.9m
+19.08%
|
$620.4m
-6.27%
|
$617.5m
-0.47%
|
$666.5m
+7.94%
|
$691.8m
+3.79%
|
|
| Gross Profit | $180.9m |
$189.0m
+4.51%
|
$204.3m
+8.06%
|
$211.4m
+3.48%
|
$223.9m
+5.93%
|
$243.2m
+8.61%
|
$280.5m
+15.33%
|
$302.1m
+7.70%
|
$336.2m
+11.31%
|
$370.6m
+10.24%
|
$394.1m
+6.34%
|
|
| Interest Income (Expense), Net | — | — | ($7.6m) |
($6.0m)
+21.71%
|
($4.4m)
+25.51%
|
($2.5m)
+44.67%
|
($10.3m)
-318.08%
|
($22.6m)
-120.23%
|
— | — | — | |
| Research and Development Expense | $7.3m | $9.3m | $11.6m | $11.4m | $10.3m | $13.5m | $12.2m | $15.0m | $16.8m | $18.5m | $17.8m | |
| General and Administrative Expense | $27.5m | $27.7m | $27.7m | $36.5m | $43.8m | $41.7m | $55.7m | $53.4m | $67.6m | $67.4m | $68.4m | |
| Amortization of Intangible Assets | $29.8m | $26.8m | $25.0m | $25.8m | $27.8m | $25.1m | $27.3m | $28.0m | $19.2m | $17.0m | — | |
| Operating Expenses | $90.0m | $91.8m | $96.5m | $108.8m | $112.8m | $115.7m | $135.3m | $142.9m | $153.3m | $161.3m | $172.4m | |
| Operating Income (Loss) | $90.8m |
$97.3m
+7.06%
|
$107.8m
+10.79%
|
$102.6m
-4.82%
|
$111.1m
+8.38%
|
$127.5m
+14.71%
|
$145.2m
+13.87%
|
$159.2m
+9.65%
|
$182.9m
+14.90%
|
$209.3m
+14.44%
|
$221.7m
+5.92%
|
|
| Interest Expense | $7.3m | $7.5m | — | — | — | — | — | — | — | — | $9.1m | |
| Investment Income, Interest | $9k | $12k | — | — | — | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | ($648k) | ($1.2m) | ($1.1m) | ($116k) | ($291k) | $187k | ($1.2m) | $681k | $72k | ($77k) | — | |
| Nonoperating Income (Expense) | ($7.9m) | ($8.8m) | — | ($6.1m) | ($4.7m) | ($2.3m) | ($11.4m) | ($21.9m) | ($16.5m) | ($10.3m) | — | |
| Interest Income (Expense), Nonoperating, Net | — | — | — | — | — | — | — | — | ($16.5m) | ($10.2m) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | — | — | — | — | — | — | — | — | $173.0m | $212.4m | |
| Income Tax Expense (Benefit) | $27.0m | ($1.6m) | $20.5m | $16.8m | $21.8m | $29.1m | $28.4m | $28.7m | $38.0m | $44.2m | $48.0m | |
| Net Income (Loss) Attributable to Parent | $56.0m |
$90.1m
+60.92%
|
$78.6m
-12.77%
|
$79.7m
+1.40%
|
$84.6m
+6.22%
|
$96.1m
+13.57%
|
$105.4m
+9.64%
|
$108.5m
+3.01%
|
$128.5m
+18.36%
|
$154.8m
+20.53%
|
$164.4m
+6.18%
|
|
| Earnings Per Share, Basic | $1.78 | $2.83 | $2.45 | $2.48 | $2.63 | $2.98 | $3.29 | $3.38 | $3.97 | $4.80 | $5.11 | |
| Earnings Per Share, Diluted | $1.75 | $2.79 | $2.42 | $2.45 | $2.60 | $2.94 | $3.25 | $3.35 | $3.93 | $4.75 | $5.08 | |
| Common Stock, Dividends, Per Share, Declared | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.65 | $0.71 | $0.87 | $0.96 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 31.5m | 31.8m | 32.1m | 32.1m | 32.2m | 32.2m | 32.0m | 32.1m | 32.3m | 32.3m | 32.1m | |
| Weighted Average Number of Shares Outstanding, Diluted | 31.9m | 32.2m | 32.4m | 32.5m | 32.5m | 32.7m | 32.4m | 32.4m | 32.7m | 32.6m | 32.4m | |
| Additional Financial Items | ||||||||||||
| Goodwill, Impairment Loss | — | — | — | — | $1.2m | — | — | — | — | — | — | |
| Selling Expense | $55.2m | $54.7m | $57.2m | $60.9m | $58.6m | $60.4m | $67.4m | $74.4m | $68.9m | $75.4m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.